Allergies
Studies from A. Rosenblut et al provide new data on allergies
Published in Hospital Law Weekly, November 22nd, 2007
"Fluticasone furoate is a novel-enhanced affinity glucocorticoid and its long-term safety must be assessed. This study was designed to assess the safety and tolerability of 12-month intranasal administration of fluticasone furoate in adult and adolescent patients with perennial allergic rhinitis (PAR) In this randomized, double-blind, placebo-controlled, parallel-group study, 806 patients with PAR were randomized to once daily (od) fluticasone furoate nasal spray 110 mu g (n = 605) or vehicle placebo nasal spray (n = 201) for 12 months, following a 7- to 14-day screening period," researchers in Santiago, Chile report.
"Safety was assessed by monitoring adverse events...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2007-11-22)
More Articles from Hospital Law Weekly
- Anesthesia
Team Finance LLC Announces Third Quarter 2007 Results - Artificial Grafts
Phoenix Hospital and Two Doctors' Groups to Pay U.S. $6.7 Million to Settle False Claims Act Allegations - Cardiovascular Disease
Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter - Health Economics
Scientists at University of Nottingham release new data on health economics - Health Insurance
Social Justice Issues Take Main Stage at Egypt's National Democratic Party Convention - Induced Abortion
Researchers from West Virginia University, Department of Obstetrics describe findings in induced abortion - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
